[go: up one dir, main page]

WO2011059189A3 - Méthode d'identification de cellules souches mésenchymateuses par emploi d'un anticorps anti-tm4sf1 et composition - Google Patents

Méthode d'identification de cellules souches mésenchymateuses par emploi d'un anticorps anti-tm4sf1 et composition Download PDF

Info

Publication number
WO2011059189A3
WO2011059189A3 PCT/KR2010/007396 KR2010007396W WO2011059189A3 WO 2011059189 A3 WO2011059189 A3 WO 2011059189A3 KR 2010007396 W KR2010007396 W KR 2010007396W WO 2011059189 A3 WO2011059189 A3 WO 2011059189A3
Authority
WO
WIPO (PCT)
Prior art keywords
mesenchymal stem
stem cells
identifying
tm4sf1
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2010/007396
Other languages
English (en)
Korean (ko)
Other versions
WO2011059189A2 (fr
Inventor
김호언
배소현
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aprogen Inc
Original Assignee
Aprogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aprogen Inc filed Critical Aprogen Inc
Publication of WO2011059189A2 publication Critical patent/WO2011059189A2/fr
Publication of WO2011059189A3 publication Critical patent/WO2011059189A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une méthode d'identification ou de séparation de cellules souches mésenchymateuses par emploi d'une protéine TM4SF1 spécifiquement exprimée dans les cellules souches mésenchymateuses. Plus spécifiquement, la présente invention concerne une composition contenant un anticorps anti-TM4SF1 pour l'identification ou la séparation de cellules souches mésenchymateuses, et une puce à protéines et un kit d'identification de cellules souches mésenchymateuses contenant un anticorps anti-TM4SF1. En outre, la présente invention concerne une méthode d'identification de cellules souches mésenchymateuses par emploi d'un anticorps anti-TM4SF1, ainsi qu'une méthode de séparation et de purification desdites cellules souches.
PCT/KR2010/007396 2009-11-13 2010-10-27 Méthode d'identification de cellules souches mésenchymateuses par emploi d'un anticorps anti-tm4sf1 et composition Ceased WO2011059189A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090109863A KR101168224B1 (ko) 2009-11-13 2009-11-13 항-ｔｍ4ｓｆ1 항체를 이용한 중간엽줄기세포 동정방법 및 그 조성물
KR10-2009-0109863 2009-11-13

Publications (2)

Publication Number Publication Date
WO2011059189A2 WO2011059189A2 (fr) 2011-05-19
WO2011059189A3 true WO2011059189A3 (fr) 2011-09-29

Family

ID=43992179

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/007396 Ceased WO2011059189A2 (fr) 2009-11-13 2010-10-27 Méthode d'identification de cellules souches mésenchymateuses par emploi d'un anticorps anti-tm4sf1 et composition

Country Status (2)

Country Link
KR (1) KR101168224B1 (fr)
WO (1) WO2011059189A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180059109A1 (en) * 2016-08-31 2018-03-01 Meridigen Biotech Co., Ltd. Method of distinguishing mesenchymal stem cells and method of determining purity of mesenchymal stem cells
WO2019015696A2 (fr) * 2017-07-17 2019-01-24 同济大学苏州研究院 Nouvelle cible pour traiter le cancer
CN109265546B (zh) * 2017-07-17 2022-05-24 同济大学苏州研究院 用于治疗癌症的新靶标
CN109342739A (zh) * 2018-11-27 2019-02-15 上海科医联创生物科技有限公司 一种鉴定间充质干细胞纯度的方法
US20220347225A1 (en) * 2019-08-07 2022-11-03 Konkuk University Industrial Cooperation Corp. Composition comprising skeletal muscle stem cell-derived exosome as active ingredient for improving skin condition

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANDREW, C. ET AL., J. CELL. BIOCHEM., vol. 89, no. 1, 2003, pages 56 - 66 *
BAE, S. ET AL., CELL TISSUE RES., vol. 335, no. 3, March 2009 (2009-03-01), pages 565 - 573 *
KIM, Y. ET AL., PFLUGERS ARCH.-EUR J PHYSIOL, vol. 455, no. 2, 2007, pages 283 - 296 *
SHIN, S. ET AL., CANCER RESEARCH, 7 April 2009 (2009-04-07) *
WAGNER, W. ET AL., EXPERIMENTAL HEMATOLOGY, vol. 33, 2005, pages 1402 - 1416 *

Also Published As

Publication number Publication date
WO2011059189A2 (fr) 2011-05-19
KR101168224B1 (ko) 2012-07-24
KR20110053059A (ko) 2011-05-19

Similar Documents

Publication Publication Date Title
IL267371B (en) Prolipotent stem cell growth medium, containing human serum, and without a nutrient layer
WO2010039802A3 (fr) Procédés et compositions pour isoler un acide nucléique
WO2009149956A3 (fr) Protéine de fusion et son utilisation
WO2010088633A3 (fr) Nouvelles lignées cellulaires et procédés
WO2005021728A3 (fr) Populations de cellules progenitrices et de cellules souches pancreatiques enrichies, methodes d'identification, d'isolement et d'enrichissement de ces populations
WO2012009644A3 (fr) Procédés pour identifier des éléments d'arn synthétiques et naturels qui améliorent la traduction des protéines
WO2006105152A3 (fr) Compositions a base de cellules amniotiques, methodes de production et utilisations desdites compositions
EP2808393A3 (fr) Cellules de déficience fucosylation
WO2007084321A3 (fr) Anticorps dirigés contre ox-2/cd200 et utilisations correspondantes
WO2010129441A3 (fr) Procédé de séparation de cellules souches à partir de leur descendance plus différenciée à l'aide de dispositifs microfluidiques
WO2011047087A3 (fr) Détection de protéine par l'intermédiaire de nanorapporteurs
IL189555A0 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
EP4249605A3 (fr) Procédés de détection d'analyte
WO2007079183A3 (fr) Populations de cellules souches placentaires
SG170065A1 (en) Human embryonic stem cell methods and podxl expression
WO2009123762A3 (fr) Procédé de criblage de cellules individuelles pour la production d'agents biologiquement actifs
ATE517192T1 (de) Verfahren zur isolierung von zellen
WO2011062803A3 (fr) Immuno-essais multiplex pour hémoglobine, variations d'hémoglobine et formes glycatées
IL189882A0 (en) Method of deriving mesenchymal stem cells
WO2008063675A3 (fr) Cellules progénitrices endothermiques
WO2009102569A3 (fr) Nouvelles lignées cellulaires et méthodes associées
WO2010048190A3 (fr) Anticorps se liant à il-12 et procédés de purification de ceux-ci
WO2012122314A3 (fr) Systèmes de purification rapide de cellules
WO2008067423A3 (fr) Procédé d'amélioration de l'introduction d'adn dans des cellules bactériennes
UA95936C2 (ru) Способ выделения бетаина

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10830122

Country of ref document: EP

Kind code of ref document: A2